4.5 Article

Cytotoxic concentrations of α-defensins in the lungs of individuals with α1-antitrypsin deficiency and moderate to severe lung disease

Journal

CYTOKINE
Volume 32, Issue 1, Pages 1-6

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.cyto.2005.06.003

Keywords

alpha(1)-antitrypsin deficiency; neutrophil elastase; bronchoalveolar lavage; human neutrophil peptide; cytotoxicity

Funding

  1. NHLBI NIH HHS [5K24HL004456] Funding Source: Medline

Ask authors/readers for more resources

The lungs of individuals with alpha(1)-antitrypsin (alpha(1)-AT) deficiency have a reduced antiprotease protective shield. Typically, numbers of neutrophils are elevated in the lungs of affected individuals, carrying large amounts of neutrophil elastase (NE) and alpha-defensins that are released upon activation. We hypothesized that in individuals with advanced lung disease associated with alpha(1)-AT deficiency cytotoxic concentrations of a-defensins might be present and unopposed, thus further aggravating lung disease. To evaluate this hypothesis, bronchoalveolar lavage was performed in 20 alpha(1)-AT deficient individuals with moderate to severe lung function impairment and 13 healthy volunteers. Cell counts as well as concentrations of NE and a-defensins were determined. While concentrations of NE were low (23 +/- 14 nM) and alpha-defensins were undetectable in volunteers, they were significantly elevated in individuals with alpha(1)-AT deficiency (1313 +/- 723 nM and 6605 +/- 2856 nM, both p < 0.0001). These concentrations were significantly higher than those found in a historical control of alpha(1)-AT deficient individuals with mild lung disease. Neutrophil numbers and NE concentration correlated with a-defensins concentration (r = 0.612 and r = 0.758, p = 0.005 and p = 0.0001, respectively). Individuals with alpha(1)-AT deficiency and moderate to severe lung function impairment have lung a-defensins concentrations in a range known to induce cytotoxicity in vitro in the absence of normal amounts alpha(1)-AT and thus may contribute to the development of lung disease in this population. (c) 2005 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available